Cargando…

Uterine Development During Induced Puberty in Girls with Turner Syndrome

OBJECTIVE: Most girls and women with Turner syndrome (TS) require estrogen replacement therapy (ERT) to initiate or maintain pubertal development. Most likely, the most fundamental effect of ERT in hypogonadism is the promotion of uterine growth. The optimal ERT model is still being discussed. The p...

Descripción completa

Detalles Bibliográficos
Autores principales: Obara-Moszynska, Monika, Dzialach, Lukasz, Rabska-Pietrzak, Barbara, Niedziela, Marek, Kapczuk, Karina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8290974/
https://www.ncbi.nlm.nih.gov/pubmed/34295308
http://dx.doi.org/10.3389/fendo.2021.707031
_version_ 1783724557756006400
author Obara-Moszynska, Monika
Dzialach, Lukasz
Rabska-Pietrzak, Barbara
Niedziela, Marek
Kapczuk, Karina
author_facet Obara-Moszynska, Monika
Dzialach, Lukasz
Rabska-Pietrzak, Barbara
Niedziela, Marek
Kapczuk, Karina
author_sort Obara-Moszynska, Monika
collection PubMed
description OBJECTIVE: Most girls and women with Turner syndrome (TS) require estrogen replacement therapy (ERT) to initiate or maintain pubertal development. Most likely, the most fundamental effect of ERT in hypogonadism is the promotion of uterine growth. The optimal ERT model is still being discussed. The present study aimed to assess uterine size in girls with TS in the prepubertal state during and after the induction of puberty and compare it to a healthy population. METHODS: The analysis encompassed 40 TS girls. The prepubertal and postpubertal control groups contained 20 healthy girls each. All patients with TS were treated with 17-ß estradiol. Uterine imaging was performed with two-dimensional (2D) transabdominal ultrasound. The uterine volume (UV) and fundocervical antero-posterior ratio (FCR) were calculated in patients with TS before the pubertal induction, after 6-12 months of estrogen replacement therapy (ERT), after ≥ 36 months of ERT or ≥ 12 months after menarche. RESULTS: The average age of TS patients at estrogen introduction and at the last control visit, when the uterus was considered mature, was 12.9 years and 16.1 years, respectively. The UV in patients with TS at the beginning of ERT was 1.55 ± 1.22 cm(3) and was not significantly different from the UV in the prepubertal controls. The mature UV in patients with TS was 31.04 ± 11.78 cm(3) and was significantly smaller than the UV of the postpubertal controls (45.68 ± 12.51 cm(3), p<0.001). The FCR in girls with TS did not differ significantly from that in the prepubertal and postpubertal control groups, respectively. No prognostic factors could be established for the final UV. By the last control visit, thelarche had advanced in most patients to Tanner 4 and 5 (37.5% and 40%, respectively). CONCLUSIONS: Before the onset of ERT, patients with TS have a uterus similar in size to that in prepubertal healthy girls. Pubertal induction in patients with TS causes a significant increase in the UV that is detectable after 6-12 months of ERT. The mature uterus is smaller in patients with TS than in the age-matched healthy population.
format Online
Article
Text
id pubmed-8290974
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-82909742021-07-21 Uterine Development During Induced Puberty in Girls with Turner Syndrome Obara-Moszynska, Monika Dzialach, Lukasz Rabska-Pietrzak, Barbara Niedziela, Marek Kapczuk, Karina Front Endocrinol (Lausanne) Endocrinology OBJECTIVE: Most girls and women with Turner syndrome (TS) require estrogen replacement therapy (ERT) to initiate or maintain pubertal development. Most likely, the most fundamental effect of ERT in hypogonadism is the promotion of uterine growth. The optimal ERT model is still being discussed. The present study aimed to assess uterine size in girls with TS in the prepubertal state during and after the induction of puberty and compare it to a healthy population. METHODS: The analysis encompassed 40 TS girls. The prepubertal and postpubertal control groups contained 20 healthy girls each. All patients with TS were treated with 17-ß estradiol. Uterine imaging was performed with two-dimensional (2D) transabdominal ultrasound. The uterine volume (UV) and fundocervical antero-posterior ratio (FCR) were calculated in patients with TS before the pubertal induction, after 6-12 months of estrogen replacement therapy (ERT), after ≥ 36 months of ERT or ≥ 12 months after menarche. RESULTS: The average age of TS patients at estrogen introduction and at the last control visit, when the uterus was considered mature, was 12.9 years and 16.1 years, respectively. The UV in patients with TS at the beginning of ERT was 1.55 ± 1.22 cm(3) and was not significantly different from the UV in the prepubertal controls. The mature UV in patients with TS was 31.04 ± 11.78 cm(3) and was significantly smaller than the UV of the postpubertal controls (45.68 ± 12.51 cm(3), p<0.001). The FCR in girls with TS did not differ significantly from that in the prepubertal and postpubertal control groups, respectively. No prognostic factors could be established for the final UV. By the last control visit, thelarche had advanced in most patients to Tanner 4 and 5 (37.5% and 40%, respectively). CONCLUSIONS: Before the onset of ERT, patients with TS have a uterus similar in size to that in prepubertal healthy girls. Pubertal induction in patients with TS causes a significant increase in the UV that is detectable after 6-12 months of ERT. The mature uterus is smaller in patients with TS than in the age-matched healthy population. Frontiers Media S.A. 2021-07-06 /pmc/articles/PMC8290974/ /pubmed/34295308 http://dx.doi.org/10.3389/fendo.2021.707031 Text en Copyright © 2021 Obara-Moszynska, Dzialach, Rabska-Pietrzak, Niedziela and Kapczuk https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Obara-Moszynska, Monika
Dzialach, Lukasz
Rabska-Pietrzak, Barbara
Niedziela, Marek
Kapczuk, Karina
Uterine Development During Induced Puberty in Girls with Turner Syndrome
title Uterine Development During Induced Puberty in Girls with Turner Syndrome
title_full Uterine Development During Induced Puberty in Girls with Turner Syndrome
title_fullStr Uterine Development During Induced Puberty in Girls with Turner Syndrome
title_full_unstemmed Uterine Development During Induced Puberty in Girls with Turner Syndrome
title_short Uterine Development During Induced Puberty in Girls with Turner Syndrome
title_sort uterine development during induced puberty in girls with turner syndrome
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8290974/
https://www.ncbi.nlm.nih.gov/pubmed/34295308
http://dx.doi.org/10.3389/fendo.2021.707031
work_keys_str_mv AT obaramoszynskamonika uterinedevelopmentduringinducedpubertyingirlswithturnersyndrome
AT dzialachlukasz uterinedevelopmentduringinducedpubertyingirlswithturnersyndrome
AT rabskapietrzakbarbara uterinedevelopmentduringinducedpubertyingirlswithturnersyndrome
AT niedzielamarek uterinedevelopmentduringinducedpubertyingirlswithturnersyndrome
AT kapczukkarina uterinedevelopmentduringinducedpubertyingirlswithturnersyndrome